SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-24-000565
Filing Date
2024-08-13
Accepted
2024-08-13 16:33:39
Documents
2
Effectiveness Date
2024-08-13

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1073
2 tenku-form25.txt EX-99.25 111
  Complete submission text file 0001354457-24-000565.txt   3107
Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE

Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
CITIUS ONCOLOGY, INC. (Subject) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 333-256271 | Film No.: 241202240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)